Therapeutic Asset Ratings
414 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
T-Dxd
Colorectal Cancer
Iambic Therapeutics, Inc
P1/2
CC
(45)
VOLITINIB
Colorectal Cancer
Fudan University
P1/2
CC
(45)
Zoladex
Colorectal Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P1/2
CC
(45)
Fosifloxuridine Nafalbenamide
Colorectal Cancer
NuCana plc
P2
CC
(43)
Tovorafenib
Colorectal Cancer
Day One Biopharmaceuticals, Inc.
P2
CC
(42)
e-602
Colorectal Cancer
Palleon Pharmaceuticals, Inc.
P1/2
CC
(42)
[111in]-fpi-1967
Colorectal Cancer
Fusion Pharmaceuticals Inc.
P1/2
CC
(40)
177lu-betabart
Colorectal Cancer
Radiopharm Theranostics, Ltd
P1/2
CC
(40)
[18F]FPyQCP
Colorectal Cancer
Blue Earth Diagnostics
P1/2
CC
(40)
[203pb]pb-psv359
Colorectal Cancer
Perspective Therapeutics
P1/2
CC
(40)
[212pb]pb-psv359
Colorectal Cancer
Perspective Therapeutics
P1/2
CC
(40)
[225Ac]-FPI-1966
Colorectal Cancer
Fusion Pharmaceuticals Inc.
P1/2
CC
(40)
64cu-lnth-1363s
Colorectal Cancer
Lantheus Medical Imaging
P1/2
CC
(40)
a2b395
Colorectal Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(40)
a2b530
Colorectal Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(40)
a2b543
Colorectal Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(40)
a2b694
Colorectal Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(40)
Afnt-211
Colorectal Cancer
Affini-T Therapeutics, Inc.
P1/2
CC
(40)
ak119
Colorectal Cancer
Akeso
P1/2
CC
(40)
Ale.P03
Colorectal Cancer
Alentis Therapeutics AG
P1/2
CC
(40)
Alintegimod
Colorectal Cancer
7 Hills Pharma, LLC
P1/2
CC
(40)
Amxt1501
Colorectal Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(40)
Apl-5125
Colorectal Cancer
Apollo Therapeutics Ltd
P1/2
CC
(40)
Ataluren
Colorectal Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
P1/2
CC
(40)
azd5305
Colorectal Cancer
AstraZeneca
P1/2
CC
(40)
Showing 176 to 200 of 414 assets
Previous
Page 8 of 17
Next